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tn the genesis of Ischemio precono~loning in man, This finding may have 
implications for the m~¢hanism of action of ACE inhibitom in ;scheme heart 
~tsease. 
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~ RMMIon ~ IN~'fuelon, Met lbo l l lm ind  
Fuect loMI  I~¢overy  Early After e, omee~/  
RlnRIl~llrt i l l l~n In l=atkmte With H lbemol lng  
MIF~.IRIlum 
F, ~ ,  A- Repoaam~, AA, Lotto. F, Borlor~. A, ParolarL E. l~ona, 
L R~.  Mo Pep, R Acetate, P. Blgli~i. O, Proof, ~ept, ot C ~  
Surgeq~ ~ ot ~ Cenao C ~  Fon0azmne I. ~-,~mo 
and CNR ~ ot Cti~cat ~ Secl~n ot Mllan. M~n, 
The ~o~e ol mis st~dy w~ lo ~ea me mcovery ot luect~ and ~ 
retat~a to ~ mye~,d~ blood ,0w (CBF~ and me~0olmm soon after 
~n,LTat~ m p= w~ I~0emalmg myacam~um 15 pm (~4 
~,  I women, mean ~ S~ ± gym) ~ n g  con~ry  a~,y  bypass 
gea l~ (I~ABG| cm !1~ left ~ dee~mding I comn~!y a~ml (LAO) 
LAD lemt0e/was ~ m an I~ ~ ~ e¢ lxx~a~l~y 
and quamMalive ~°tT| msl-te,~,~l~u~ m~a0mg. The LA~BF,  evaluatsd 
by 0nmt ~ veto ( G C ~ ~  0hem~am~ ~ ) ,  tt~ 
by ~ a n ~  echoca~,  were asm~ed ~x~ore and 20-40 
mm attm CABG. I ~  tt.mclion imlmmmd m 74% ol I1~ dysm/nergms 
twaa moron so~e ~ Worn 2.7 ± 0.7 to 1.4 ~ 0.7, p < 0.001). LAD- 
CBF mcnu~ed in aft but o~ pt aNm su~ge~J (frem 56 ± 27 to 121 -,-46 
mL~W~, p < 0.001), k lyocan~ s~bm ~azmn (ca~-xt~ as e~act~ 
and metabo~ flu-,as aooss me I~a.,I) m me LAD temtory was W~cative of 
lactate. 91utamaZe a~d fairy m:~ds uetza l~ a~d sl~j~ aPanme pnxludmn 
bek~e CABG. Mean myecem~ md~za~on ot the numswed s~0stratas ~ 
r~ change after ~ At foSow-up 74% o( I~e dys~- ,~ 
~q~gnuz~rm had fun¢~n omaf~zed or m'q~roved. In ~ m I~bemat- 
mg myocanliurn me a~, -~ metabotism is t~mu~ly  Weserved. des~e 
chn~nicagy reduced CBF a~l ~ .  The CBF impmvemen~ fogowmg 
revascumnzatm~L is assectated with an immediato functmnal ~ m 
mast of ~ secjn~.=~s. ~awng u~changed ~e me~ "u~es. 
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Tranmlemml Nitroglycerin Therapy Is Not  Ammciated 
With Biochemical  Madlem otl Ox ida lNe Stress 
SO. lt,~lone. CR Pace-~k.  ER. Azevedo, G.E. Newlort. J.D Parker 
or Torero. Canada 
Back q~ur~ Toleranco to organic mtrales may ~ caused by too'eased free 
radecal production. To dale. no hunmn sto~es have examined the m,q~aot f 
ndrale lt'mrapy on biochemcal markers ot ozidatwe swess We e~'kned I1~ 
effect of nilrale therapy on: 1) plasma 8qso-PGF2= (a slable melabolito of 
arachidoeic acid oxidalmn), 2) plasma ~loebyde (MD~ a i~oduct ot 
Iql~d pemxidatmn), and 3) plasma V~amm C (V~t C; wa HPLC) levers. 
Methods. Twemy normal males rece~-~d co,tortuous Iransdermal nmo- 
g~ycenn (TGTN) 0.6 moJhr or no therapy in a randomized, investigator blind. 
parallel destg~n 1 ~  Starting HR. SBP, ~ 8-rso.PGF2, MDA. and 
Vd C levels were measured at basehne. 3 hours ~ acute TGTN and 
after 1 week of sustaJned therapy. 
Therapy was continued and the following day all subiects recewed 2 
grams of oral Vit C or placebo in a double blind, randomized, crossover 
fashion. Belore and 90 n.n after oral Vii C. measures of SBP. HR. and 
plasma Vii C levels were obtained. 
Resutts: Acutely, TGTN caused a significant fall in SBP and an increase 
in HR. Following sustained therapy, Ix~th SBP and HR returned to baseline 
indicating the development of tolerance. 
Baseline A~-ute T~-,I N Sustained TGTN 
8-¢so-PGF2=x (pc~mL) 267 • 84 288 = 111 310 ± 110 
MDA (mmo[/L) 4.7 ± 1.0 4.6 :E 09  4,2 ± 0.7 
V=t C (~*mol/L) 56 ± 22 60 ~: 20 50 ± 25 
Acute and sustained TGTN therapy was not aSsociated with evidence of 
increa:;ed free radical production. The administration of Vit C failed to restore 
the hemodynamic effect o| TGTN (SBP: 119 + 12 vs 118 + 9 mmHg. prevs 
post Vit C) des'~ite a significant increase in plasma Vii C levels (67 ± 48 vs 
112 :~ 39 pmot~L; p < 0.01). 
Conclusion: This studS, cl,=monstrates that a clinically relevant dose of 
TGTN therapy is not associated with biochemical evidence of oxidative 
stress. Consistent with this observation, the acute administration of vita- 
min C does not restore hemodynamic responses to TGTN. This study does 
not suppml I1~ hypothesis that lrcrea~l free ra(~cal ~roduc~,1 is a c-.~t~,e 
of to~erano~ to therapy with TGTN 
Oenlt l¢ and Metabolic Risk Factorl In Acute 
Coronary Syndrome= 
Wednesday, April 1, 1998, 4:00 p.m.-5:00 p.m. 
Georgia World Congress Center. Room 257W 
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i~2:1 l  A , ,~k~ of = ~morphh,m of mo e.=.~,,L., 
. . . . . . . . .  Cormff iu lh~ Nlld¢ OMde I ! ~  O~me WNh 
I~t¢~l la l  ~ In ~ Popu~m 
S. Icmhara, Y. Yamada, I: F~um, M Yoke~a, Nagoya ~ ~ ot 
~ Nagoya, Japan 
Ba~gmun~: Nitr~ re,de (NO) aco~t~z for me t~a l  activ~fy o! e~- 
dethe l l~  re~axing ~,  ~ seem~ It) have an ~ role 
m veso~ and an inh i l~  ol platelel ag~mgation. The impoda~t 
O1 NO I.,dea.s~ in line regulation of h~ul Oe sltreulal~ vascl,llae lone 
oe~ that a~n at3~m~ NO ~ ~ co~l be ~ m a~emnl 
pamok3OmaJ con~uons such as ~ or ~ .  EnOome, 
,a~ ~ ranc oxKle W,tt, me (ecNOS) po~m~oq~srn wM ~i~/  
reported to be associated wire ceronary atom/dl~ease only in cumin1 and 
e~-smokem m Aumral~ We Ittus ~ me asse¢lalton I~wasn V=Lqa- 
Iron in me ecNOS gene a~l the presence ol myecafd~ ~aectt0n (MI) m a 
Japanase ~ ,  
Me#rod- The polymoq~ism in inlxon 4 of 1he ecNOS gene (ecNOS4a~) 
was analyzed in 455 palJee~ v~tt~ MI and 550 cenlrot eub~.  
Resu~: The frequency of me ecNOS,la allele was =gnif¢an~ r~g~er 
m thee M1 palmnts than in controls (odds farm, 1.52, p = 0.007). When g~e 
~nson was ~ to me~ or women, ttm tn~luency of the ecNOS4~ 
allete was ~ higtmr in I11e MI paben~ than in comrels m men (odds 
ratio, 1.52; p = 0.016), but not in t z~n.  In ~e low-fish ~ defim~d 
by a Zx~dy maas~ <27 kg/m z =rid no h i~ of hyponen~ diabetes 
metld-,as, or ~ 1he asz~Oatmn was espe~ly marked 
(odds rabo. 2.50; p = 0.0035). 
Conc/us~n: The polymoephism in i.i,,,~-, 4 of the ecNOS gene may be an 
independent risk factor for MI in fl'm Japanese pOlPulalion. 
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-2~ Increa~ of Human Cu-Zn Superoxlde Ex~ei ,  lzion 
in a T ~ i c  Momm Model of  
Ischemla#eperfu$1on 
J.R. Tee~;mk. N.Y. Honbo, Y-F.C Lau, JS  Kartiner VA MeoYcsI 
C~r~er.,I./CSF. San F ra~ CA. USA 
Ba~gmur~" ~ human (h-MnSOO) rnanganese-superexioe ~smutase gene 
Is really inducible by ox~ali've and omer slreasas, bul ~ role of me "con- 
~ -  human Cu-Zn SOD in me carffmc response Io ischemm m unclear. 
Our purpose was to assess ~ effect of ischemia/rsperkmon on the e~,~s- 
s~on of h-CuZnSOD in a transgen¢ mouse model (~ft from Dr. Charles J. 
Epstein). 
Meg~ds: Mv;-,e were ra t~ selected from normal CD~I controls, 
h-CuZnSOD lwterozygotes (Htz) and homozygetes (Hmz) at age 6 mont~ 
wt~ a mean .,ma~jht o{ 43 ± 3 grams. Hearts were excmed, pedmed on 
a Langendorff apparalus, and unde~ent 30 m~r~es ot tschemia fogow~l 
by 15 minutes of reperfus~n (IschRep) or perfusion for 45 minulas (Con- 
trot); experiments were perfomled in trtphcale. SOD mRNA mq~resston was 
measured on Northern ~ prepared from total mRNA isolsted from the 
mouse hearts wi~ a h-CuZnSOD probe. Two distinct bands were measured 
by densitometry at approximately 0.7 and 09  kb in Htz and Hmz mlce, the 
values adjusted for 18s intensi~, and added as total CuZn-SOD. 
Resuffs: Baseline SOD expression was increased 5.5-told in Hmz m~"e 
(D = 0.06). No s~nifcant increase in wi/d type mouse SOD during IschRt~o 
(control 0.3 ± 0.2 SO; IschRep 0.4 ± 0.2 units) was noted, although SOD 
transgene express~n markeo]y increased tn boffl Htz (p < 0.01) and Hmz 
(p < 0.05) to 3.0 ± 1.3 and 2.9 ± 0.7 units, respectively, These findings 
suggest minimal activation of the native mouse CuZnSOD in response to 
IschRep. elevated baseline h-CuZnSOD expression in the Hmz mice. and 
marked induction of Iransgene transcription in ~ to IschRep. 
Condus/on: The expression of the constitutively expressed h-CuZn SOD 
gene is incompletely understood; in this transgenic model, it was readily 
inducible. Further study of this increased expression in response to/schRep 
may contffbute to an increased understanding of the mechaniSm of myocar- 
dial salvage in ischemic states. 
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